Trial intelligence / Profile preview

1 Hz single-twitch monitoring to improve assessment of rocuronium onset

NL-OMON32338Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of rocuronium, sponsored by University Medical Center Groningen. Primary endpoint: Prediction accuracy of PK-PD-potentiation model. Started Apr 2009; status: active, not recruiting.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NL-OMON32338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call